Detection method of impurities in nikethamide raw materials

The detection method for nikethamide raw material was optimized by high performance liquid chromatography. By using a specific chromatographic column and gradient elution technology, the problem of insufficient separation of impurities in nikethamide raw material was solved, and efficient and accurate impurity detection was achieved, ensuring product quality and pharmaceutical safety.

CN118641677BActive Publication Date: 2024-11-05BEIJING JINGFENG PHARMA GRP +2
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411124969.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-16
Publication Date
2024-11-05
Estimated Expiration
2044-08-16

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively distinguish and detect nitrogen oxide impurities and other related substances in nikethamide raw materials, leading to mutual interference in detection, failure to meet separation requirements, and impacting product quality control and pharmaceutical safety.

Method used

High performance liquid chromatography was used with a phenomenex luna C18(2) column, with phosphoric acid aqueous solution as mobile phase A and methanol as mobile phase B, and gradient elution was performed to optimize the detection conditions and improve the separation and peak shape between impurities.

Benefits of technology

This technology enables the efficient separation and detection of various impurities in nikethamide raw materials, improving the specificity, repeatability, sensitivity, and accuracy of the detection, and ensuring the stability of product quality and pharmaceutical safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118641677B_ABST
    Figure CN118641677B_ABST
Patent Text Reader

Abstract

The present invention provides a method for detecting impurities in nikethamide raw materials, and relates to the technical field of drug detection and separation. The detection method is to detect by high performance liquid chromatography, and the chromatographic conditions are: using a phenomenex luna C18 (2) chromatographic column, using phosphoric acid aqueous solution as mobile phase A, and using methanol as mobile phase B, and performing gradient elution. The detection method of the present invention can detect various impurities in nikethamide raw materials, wherein the impurities in the nikethamide raw materials include nicotinic acid, nicotinic acid nitrogen oxides, ethyl nicotinamide, N Any one of 2-ethylnicotinamide nitrogen oxide, 3-cyanopyridine or nikethamide nitrogen oxide or a combination of at least two thereof. The method of the present invention can realize efficient separation and detection of nikethamide and its related substances, and can effectively control the quality of drugs.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of drug detection and separation, in particular to a method for detecting impurities in a minnicethamide raw material. Background Art

[0002] Nikethamide is a colorless or slightly yellow oily liquid with a slightly peculiar odor and bitter taste. It is made by the reaction of nicotine (nicotinic acid) acid and benzenesulfonyl diethylamide. Nikethamide can be mixed with water, ethanol, and chloroform at will. This product can selectively excite the medullary respiratory center, and act on the carotid body and aortic body chemoreceptors to reflexively excite the respiratory center, and weakly excite the vasomotor center. It is suitable for the rescue of central respiratory and circulatory failure and central inhibitory drug poisoning.

[0003] The raw material nikethamide is included in Ch.p2020, EP11.2 and BP2023, and none of them controls nikethamide nitrogen oxides. The comparison of pharmacopoeia methods is shown below:

[0004]

[0005] Considering that the detection specificity and sensitivity of TLC method are weaker than HPLC, the Chinese Pharmacopoeia method is generally used to detect nikethamide to control its product quality. However, in the detection of related substances in nikethamide raw materials, the detection method of the Chinese Pharmacopoeia cannot strictly control the nitrogen oxide impurities and other related impurities contained therein. When the raw material contains multiple impurities at the same time, nikethamide nitrogen oxide, nicotinic acid, 3-cyanopyridine, ethyl nicotinamide, nicotinic acid nitrogen oxide, N -ethylnicotinamide nitrogen oxides, due to the certain similarity in the structures of these compounds, the detection will interfere with each other, making it difficult to accurately distinguish different related substances. For example, the above-mentioned method disclosed in the Chinese Pharmacopoeia will have many problems in detection: for example, the retention time of 3-cyanopyridine and ethylnicotinamide impurities is the same, and the separation degree does not meet the requirements; the separation degree of nicotinic acid nitrogen oxides and ethylnicotinamide is poor, and it does not meet the detection requirements; the peak shape of nicotinic acid nitrogen oxides is poor; the nicotinic acid peak is tailing and the peak shape is poor.

[0006] In view of this, the present invention is proposed. Summary of the invention

[0007] The purpose of the present invention is to provide a method for detecting impurities in nikethamide raw materials. The detection method of the present invention can simultaneously detect nikethamide nitrogen oxides and other related substances in the nikethamide raw materials, and the detection process has good repeatability, high sensitivity, good peak shape, high separation, stable and reliable peak time, good durability, and improved detection efficiency and detection accuracy, so as to effectively control and master the product quality of nikethamide raw materials and ensure the safety of medicinal use.

[0008] In order to achieve the above-mentioned purpose of the present invention, the following technical solutions are particularly adopted:

[0009] The present invention provides a method for detecting impurities in a nikethamide raw material, wherein the detection method is performed by high performance liquid chromatography, and the chromatographic conditions are:

[0010] A phenomenex luna C18(2) column was used for gradient elution with aqueous phosphoric acid as mobile phase A and methanol as mobile phase B;

[0011] Wherein, the impurities in the nikethamide raw material include nicotinic acid, nicotinic acid nitrogen oxide, ethyl nicotinamide, N Any one of -ethylnicotinamide N-oxide, 3-cyanopyridine or nikethamide N-oxide, or a combination of at least two thereof.

[0012] Furthermore, the specifications of the chromatographic column are 250×4.6 mm, 5 μm.

[0013] Furthermore, the mobile phase A is a 0.04-0.06 vol% phosphoric acid aqueous solution.

[0014] Furthermore, the conditions of the gradient elution include:

[0015] 0-5 min, the volume ratio of mobile phase A was 95%, and the volume ratio of mobile phase B was 5%;

[0016] 5-20 min, mobile phase A volume ratio is 95-90%, mobile phase B volume ratio is 5-10%;

[0017] 20-30 min, mobile phase A volume ratio is 90-35%, mobile phase B volume ratio is 10-65%;

[0018] 30-40 min, mobile phase A volume ratio is 35%, mobile phase B volume ratio is 65%.

[0019] Furthermore, the conditions of the gradient elution also include:

[0020] 40-40.01 min, the volume ratio of mobile phase A was 35-95%, and the volume ratio of mobile phase B was 65-5%;

[0021] 40.01-50 min, the volume ratio of mobile phase A was 95%, and the volume ratio of mobile phase B was 5%.

[0022] Furthermore, the detection method comprises the following steps:

[0023] Dissolving the nikethamide raw material in the mobile phase A to obtain a test solution; and then injecting the test solution into a high performance liquid chromatograph for detection and separation;

[0024] Furthermore, the concentration of the test solution is 3.0~5.0 mg / mL.

[0025] Furthermore, the detection flow rate is 0.8~1.2 mL / min.

[0026] Furthermore, the column temperature of the detection is 25~35°C.

[0027] Furthermore, the detection wavelength is 260~265 nm.

[0028] Furthermore, the injection volume of the detection is 8~12 μL.

[0029] Compared with the prior art, the present invention has the following beneficial effects:

[0030] (1) The detection method of the present invention can simultaneously detect multiple impurities in nikethamide raw materials, including nikethamide nitrogen oxides and other related substances, such as nicotinic acid, nicotinic acid nitrogen oxides, ethyl nicotinamide, N -Ethylnicotinamide N-oxide, 3-cyanopyridine and nikethamide N-oxide, with good peak shape, high separation and stable and reliable peak elution time.

[0031] (2) The detection method of the present invention has good specificity, strong repeatability, high sensitivity, accuracy, solution stability and durability, thereby effectively controlling and mastering the product quality of nikethamide raw materials and ensuring the safety of medicinal use. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0033] Figure 1 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Example 1.

[0034] Figure 2 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Comparative Example 1.

[0035] Figure 3 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Comparative Example 2.

[0036] Figure 4 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Comparative Example 3.

[0037] Figure 5 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Comparative Example 4.

[0038] Figure 6 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Comparative Example 5.

[0039] Figure 7 The chromatogram of the results of the method for detecting impurities in the nikethamide raw material is provided for Comparative Example 6. DETAILED DESCRIPTION

[0040] Unless otherwise defined herein, scientific and technical terms used in conjunction with the present invention shall have the meanings commonly understood by those of ordinary skill in the art. The meaning and scope of the terms should be clear, however, in the case of any potential ambiguity, the definitions provided herein take precedence over any dictionary or external definitions. In this application, unless otherwise stated, the use of "or" means "and / or". In addition, the use of the term "including" and other forms is non-limiting.

[0041] It should be noted that specific details are described in the following description to facilitate a full understanding of the present invention. However, the present invention can be implemented in a variety of other ways different from those described herein, and those skilled in the art can make similar generalizations without violating the connotation of the present invention. Therefore, the present invention is not limited to the specific embodiments disclosed below.

[0042] The technical solution of the present invention will be clearly and completely described below in conjunction with the embodiments. Obviously, the described embodiments are part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0043] The present invention replaces a method for detecting impurities in a nikethamide raw material, wherein the detection method is to detect by high performance liquid chromatography, and the chromatographic conditions are:

[0044] A phenomenex luna C18(2) column was used for gradient elution with aqueous phosphoric acid as mobile phase A and methanol as mobile phase B;

[0045] Wherein, the impurities in the nikethamide raw material include nicotinic acid, nicotinic acid nitrogen oxide, ethyl nicotinamide, N Any one of -ethylnicotinamide N-oxide, 3-cyanopyridine or nikethamide N-oxide, or a combination of at least two thereof.

[0046] In the present invention, a specific phenomenex luna C18 (2) chromatographic column is selected, and a phosphoric acid aqueous solution is used as the mobile phase A, and methanol is used as the mobile phase B, and gradient elution is performed, which is suitable for the detection of the above-mentioned multiple nikethamide-related substances and related nitrogen oxide impurities, and can effectively improve the separation between impurities and between the main peak and the adjacent impurities, and the peak shape of each impurity peak is good, and the peak time is stable and reliable. The detection process using the detection method of the present invention can further improve the specificity, repeatability, sensitivity, accuracy, solution stability, and durability, so as to more effectively control and master the product quality of the nikethamide raw material and ensure the safety of medicinal use.

[0047] It should be noted that one of the major difficulties to be solved by the present invention is the separation of related substances and related nitrogen oxide impurities. Since the structural properties of the substances themselves have certain similarities, the use of general separation methods can easily lead to the overlap of adjacent peak positions, the same or similar retention times, and poor separation, especially for the separation of nicotinic acid and nicotinic acid nitrogen oxides, ethyl nicotinamide and N The separation of 1-ethylnicotinamide nitrogen oxide, the separation of the main peak of nikethamide and 3-cyanopyridine impurities, and the separation of nikethamide and nikethamide nitrogen oxide are all difficult. Therefore, the present invention selects a phenomenex lunaC18 (2) chromatographic column, and uses an aqueous phosphoric acid solution as the mobile phase A and methanol as the mobile phase B for gradient elution, which can effectively improve the peak shape of the above impurities of the present invention and significantly improve the separation between the impurity peaks. The above chromatographic column has a wide pH stability, which can achieve a longer chromatographic column life and higher method flexibility.

[0048] Among them, the structure of the above-mentioned nikethamide-related substance impurity is as follows:

[0049] .

[0050] As an optional embodiment of the present invention, the specifications of the chromatographic column are 250×4.6 mm, 5 μm.

[0051] As an optional embodiment of the present invention, the mobile phase A is a 0.04-0.06 vol% phosphoric acid aqueous solution, for example, it can be 0.04 vol%, 0.045 vol%, 0.05 vol%, 0.055 vol%, 0.06 vol%, etc.

[0052] In the present invention, a certain amount of phosphoric acid is added. Phosphoric acid has a buffering effect and a stable pH. Most importantly, compared with other acids, it can effectively avoid the problem of impurity peak positions overlapping and retention times being the same or similar, and significantly improves the separation between impurities and between the main peak and adjacent impurities.

[0053] As an optional embodiment of the present invention, the conditions of the gradient elution include:

[0054] 0-5 min, the volume ratio of mobile phase A was 95%, and the volume ratio of mobile phase B was 5%;

[0055] 5-20 min, mobile phase A volume ratio is 95-90%, mobile phase B volume ratio is 5-10%;

[0056] 20-30 min, mobile phase A volume ratio is 90-35%, mobile phase B volume ratio is 10-65%;

[0057] 30-40 min, mobile phase A volume ratio is 35%, mobile phase B volume ratio is 65%.

[0058] In the present invention, the separation between impurities and between the main peak and adjacent impurities is further improved by further optimizing the gradient elution procedure, the peak elution time is stabilized, and the detection specificity, repeatability, sensitivity, accuracy, etc. are further improved.

[0059] As an optional embodiment of the present invention, the conditions of the gradient elution also include:

[0060] 40-40.01 min, the volume ratio of mobile phase A was 35-95%, and the volume ratio of mobile phase B was 65-5%;

[0061] 40.01-50 min, the volume ratio of mobile phase A was 95%, and the volume ratio of mobile phase B was 5%.

[0062] As an optional embodiment of the present invention, the detection method comprises the following steps:

[0063] The nikethamide raw material is dissolved in the mobile phase A to obtain a test solution; and the test solution is then injected into a high performance liquid chromatograph for detection and separation.

[0064] As an optional embodiment of the present invention, the concentration of the test solution is 3.0~5.0 mg / mL, for example, it can be 3.0 mg / mL, 3.2 mg / mL, 3.4 mg / mL, 3.6 mg / mL, 3.8 mg / mL, 4.0 mg / mL, 4.2 mg / mL, 4.4 mg / mL, 4.6 mg / mL, 4.8 mg / mL, 5.0 mg / mL, etc.

[0065] As an optional embodiment of the present invention, the detected flow rate is 0.8~1.2 mL / min, for example, it can be 0.8 mL / min, 0.9 mL / min, 0.95 mL / min, 1.0 mL / min, 1.05 mL / min, 1.1 mL / min, 1.2 mL / min, etc., preferably 1.0 mL / min.

[0066] As an optional embodiment of the present invention, the detected column temperature is 25-35°C, for example, it can be 25°C, 26°C, 27°C, 28°C, 29°C, 30°C, 31°C, 32°C, 33°C, 34°C, 35°C, etc., preferably 30°C.

[0067] As an optional embodiment of the present invention, the detected wavelength is 260-265 nm, for example, it can be 260 nm, 261 nm, 262 nm, 263 nm, 264 nm, 265 nm, etc., preferably 263 nm.

[0068] As an optional embodiment of the present invention, the injection volume for the detection is 8-12 μL, for example, it can be 8 μL, 9 μL, 10 μL, 11 μL, 12 μL, etc., preferably 10 μL.

[0069] The present invention is further described below by way of examples. Unless otherwise specified, the materials in the examples are prepared according to existing methods or directly purchased from the market.

[0070] Among them, the impurity information of nikethamide related substances is as follows:

[0071]

[0072] Among them, the test product information of nikethamide is as follows:

[0073]

[0074] Example 1

[0075] The present embodiment provides a method for detecting impurities in a nikethamide raw material, and the method for detecting impurities in a nikethamide raw material comprises the following steps:

[0076] I. Chromatographic conditions:

[0077] Chromatographic column: phenomenex luna C18 (2) 250×4.6mm, 5μm 171#;

[0078] Mobile phase A: 0.05% phosphoric acid solution;

[0079] Mobile phase B: methanol;

[0080] Column temperature: 30°C;

[0081] Detection wavelength: 263 nm;

[0082] Injection volume: 10 μL;

[0083] Flow rate: 1.0 mL / min;

[0084] Gradient Program:

[0085]

[0086] Ⅱ. Solution preparation:

[0087] Solvent: Mobile phase A

[0088] Preparation of test solution: Take 80 mg of nikethamide, weigh accurately, place in a 20 mL volumetric flask, add appropriate amount of solvent to dissolve and dilute to scale, shake well. (4 mg / mL).

[0089] Self-control solution: Accurately measure 1 mL of the test solution, place it in a 100 mL volumetric flask, dilute to the mark with solvent, and shake well. (1%)

[0090] Impurity stock solution: take nicotinic acid, 3-cyanopyridine, ethyl nicotinamide, nicotinic acid nitrogen oxide, N Accurately weigh about 4 mg each of -ethylnicotinamide N-oxide and nikethamide N-oxide, place in 20 mL volumetric flasks, add appropriate amount of solvent to dissolve and dilute to the scale, and shake well.

[0091] Mixed impurity stock solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in a 10 mL volumetric flask, dilute to the mark with solvent, and shake well.

[0092] Positioning solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in 10 mL volumetric flasks, dilute to the mark with solvent, shake well, and use them as the respective impurity positioning solutions.

[0093] System suitability solution: Take about 80 mg of nikethamide, weigh accurately, place in a 20 mL volumetric flask, accurately add 4 mL of mixed impurity stock solution, dilute to the scale with solvent, and shake well.

[0094] III. Operation:

[0095] Accurately measure 10 μL of the above solvents, system suitability solution, each impurity location solution, test solution and reference solution and inject them into the liquid chromatograph to record the chromatogram.

[0096] IV. Test results:

[0097] As shown in Table 1 below:

[0098] Table 1

[0099]

[0100] As shown in Table 1 above and below Figure 1 As shown, the blank solvent does not interfere with the detection, and the separation between each known impurity and between the main peak and the adjacent impurities meets the requirements. This method effectively avoids the problem of impurity peak positions overlapping and retention times being the same or similar, and significantly improves the separation between impurities and between the main peak and adjacent impurities, with the separation reaching more than 10. The method of the present invention is suitable for the detection of nikethamide-related substances and related nitrogen oxide impurities, and can effectively detect and separate N -Ethylnicotinamide N-oxide, nikethamide N-oxide, 3-cyanopyridine, ethylnicotinamide, nicotinic acid N-oxide, nicotinic acid and nikethamide.

[0101] Example 2

[0102] This embodiment provides a method for detecting impurities in nikethamide raw materials, which is different from Example 1 only in that the detection flow rate is reduced to 0.8 mL / min, and the other steps are completely consistent with Example 1.

[0103] Example 3

[0104] This embodiment provides a method for detecting impurities in nikethamide raw materials, which is different from Example 1 only in that the detection flow rate is increased to 1.2 mL / min, and the other steps are completely consistent with Example 1.

[0105] Example 4

[0106] This embodiment provides a method for detecting impurities in a nikethamide raw material, which is different from Example 1 only in that the volume percentage of phosphoric acid in the phosphoric acid aqueous solution is reduced to 0.04%, and the other steps are completely consistent with Example 1.

[0107] Example 5

[0108] This embodiment provides a method for detecting impurities in a nikethamide raw material, which is different from Example 1 only in that the volume percentage of phosphoric acid in the phosphoric acid aqueous solution is increased to 0.06%, and the other steps are completely consistent with Example 1.

[0109] Example 6

[0110] This embodiment provides a method for detecting impurities in nikethamide raw materials, which is different from Example 1 only in that the column temperature of the detection is adjusted to 25° C., and the other steps are completely consistent with Example 1.

[0111] Example 7

[0112] This embodiment provides a method for detecting impurities in nikethamide raw materials, which is different from Example 1 only in that the column temperature of the detection is adjusted to 35° C., and the other steps are completely consistent with Example 1.

[0113] Example 8

[0114] This embodiment provides a method for detecting impurities in nikethamide raw materials. The only difference from Example 1 is that another chromatographic column of the same model, phenomenex luna C18 (2) 250×4.6 mm, 5 μm 171#, is selected, and the other steps are completely consistent with Example 1.

[0115] Test Example 1

[0116] Methodological validation

[0117] The detection methods provided in the above Examples 1 to 8 were validated by methodology. This method has good specificity, repeatability, accuracy, solution stability, and durability. The validation results all meet the requirements. The specific validation contents and results are as follows:

[0118] (1) Exclusivity

[0119] As in Example 1, the blank solvent did not interfere with the detection, and the separation between the known impurities and between the main peak and the adjacent impurities met the requirements. The method for detecting nikethamide-related substances has good specificity.

[0120] (2) Quantification limit and detection limit

[0121] Niclosamide stock solution: Take an appropriate amount of about 80 mg of nikethamide, accurately weigh it, place it in a 20 ml volumetric bottle, add an appropriate amount of solvent to dissolve and dilute to the scale, and shake well; accurately measure 1 ml of the above solution, place it in a 100 ml volumetric bottle, add solvent to dilute to the scale, and shake well.

[0122] Take appropriate amount of nikethamide and each impurity location solution (prepared in the same way as the analytical method) and dilute them step by step with solvent. When the signal-to-noise ratio of the chromatographic peak height is greater than or equal to 10, it is taken as the quantitative limit; when the signal-to-noise ratio of the chromatographic peak height is greater than or equal to 3, it is taken as the detection limit.

[0123] The results of the quantitation limit test of nikethamide raw materials are shown in Table 2 below:

[0124] Table 2

[0125]

[0126] The results of the nikethamide raw material detection limit test are shown in Table 3 below:

[0127] Table 3

[0128]

[0129] As shown in Tables 2 and 3 above, the quantitative limits of each impurity are much less than 0.05% of the test sample concentration, and the detection limits are much less than 0.01% of the test sample concentration, indicating that the detection method provided in Example 1 has high sensitivity, can meet the detection requirements, is suitable for the detection of nikethamide-related substances and related nitrogen oxide impurities, and can effectively detect and separate N -Ethylnicotinamide N-oxide, nikethamide N-oxide, 3-cyanopyridine, ethylnicotinamide, nicotinic acid N-oxide, nicotinic acid and nikethamide.

[0130] (3) Repeatability

[0131] Take this product and prepare the solution according to Example 1. Prepare 6 test sample solutions in parallel, determine the related substances, and verify the repeatability of the method.

[0132] Methodological repeatability results (n=6) The test results are shown in Table 4 below:

[0133] Table 4

[0134]

[0135] As shown in Table 4 above, the determination results show that for the 6 parallel test solutions, the RSD of the known impurities, the largest single impurity and the total impurities is ≤5%, the number of impurities detected is consistent, and the method has good repeatability.

[0136] (4) Accuracy

[0137] Nikethamide and mixed impurity stock solution (under the solution preparation item of Example 1).

[0138] The preparation method of the recovery sample solution is shown in Table 5 below:

[0139] Table 5

[0140]

[0141] Accurately measure 10 μL of each of the above solutions (1 injection each), inject into the liquid chromatograph, and record the chromatogram. Calculate the recovery rate of each impurity using the impurity external standard method.

[0142] The accuracy test results are shown in Table 6 below:

[0143] Table 6

[0144]

[0145] As shown in Table 6 above, the determination results show that the accuracy of each known impurity in the concentration range of 50%, 100%, and 150% is within the range of 90% to 108%, which meets the requirements; it shows that the proposed method can accurately measure nicotinic acid, 3-cyanopyridine, ethyl nicotinamide, nicotinic acid nitrogen oxides, N-Ethyl nicotinamide N-oxide and nikethamide N-oxide impurities, the method has good accuracy.

[0146] (5) Solution stability

[0147] The preparation of the test solution and the self-control solution is the same as that of the solution preparation in Example 1.

[0148] The test solution was placed at room temperature and injected at 0 h, 1 h, 2 h, 4 h, and 6 h respectively. The control solution was placed at room temperature and injected at 0 h, 6 h, 8 h, 12 h, 18 h, and 24 h respectively to observe the changes in the impurity peak area of ​​the test solution and the peak area of ​​the control solution.

[0149] The results of substance solution stability - test solution are shown in Table 7 below:

[0150] Table 7

[0151]

[0152] The results of substance solution stability-control solution are shown in Table 8 below:

[0153] Table 8

[0154]

[0155] As shown in Tables 7 and 8 above, when the test solution was placed at room temperature for 1 hour, the maximum change rate of the peak area of ​​the known impurities and the largest single impurity detection in the test solution compared with 0 h was 20.00%, which was greater than 5%. The solution was unstable when placed at room temperature for 1 hour, so the test solution needed to be prepared fresh before use. When the control solution was placed at room temperature for 24 hours, the maximum change rate of the peak area was 0.25%, which was less than 5%. Therefore, the control solution can be kept stable for use within 24 hours at room temperature.

[0156] (6) Durability

[0157] Slight changes in the measurement conditions are made to examine the degree to which the measurement results are not affected.

[0158] The preparation of solvent and system suitability solution is the same as that of solution preparation in Example 1.

[0159] Adjust the determination method of nikethamide related substances according to Table 9:

[0160] Table 9

[0161]

[0162] Under the adjusted chromatographic conditions, the blank solution and system suitability solution were examined respectively.

[0163] The material inspection durability results - system suitability results are shown in Table 10 below:

[0164] Table 10

[0165]

[0166] As shown in Table 10 above, from the above test data, it can be seen that when the column temperature is adjusted by ±5°C, the flow rate changes by ±0.2 mL / min, the phosphoric acid concentration changes by ±0.01%, and the chromatographic column of the same brand but different batch number (phenomenex luna C18 (2) 250×4.6 mm, 5 μm) is replaced, the blank solvent does not interfere with the detection, the minimum separation of impurities in the system suitability solution can reach more than 8, and the separation between the main peak and the adjacent impurity peaks in the system suitability solution is greater than 1.5. Therefore, when the chromatographic conditions change slightly, it has basically no effect on the determination results of related substances of nikethamide raw materials. This method has good durability.

[0167] (7) Sample testing:

[0168] Take this product (batches 2305003, 2305004, and 2306001) and prepare the solvent, test solution, control solution, and system suitability solution according to Method 4, Solution Preparation, to determine the related substances.

[0169] The results of material methodological repeatability (n=6) are shown in Table 11 below:

[0170] Table 11

[0171]

[0172] As shown in Table 11 above, it was determined that the detected amounts of known impurities of the relevant substances in the above three batches of nikethamide were all less than 0.1%, and the detected amounts of other single impurities were all less than 0.2%, which all met the requirements for the relevant substances.

[0173] Comparative Example 1

[0174] This comparative example provides a method for detecting impurities in a nikethamide raw material, and the method for detecting impurities in the nikethamide raw material comprises the following steps:

[0175] I. Chromatographic conditions:

[0176] Chromatographic column: Aglient C18 4.6×250mm, 5 μm 125#;

[0177] Mobile phase: methanol-water (volume ratio 30:70);

[0178] Detection wavelength: 263 nm;

[0179] Injection volume: 10 μL;

[0180] Flow rate: 1.0 mL / min;

[0181] Column temperature: 25℃.

[0182] Ⅱ. Solution preparation:

[0183] Solvent: Water.

[0184] Preparation of test solution: Take 80 mg of nikethamide, weigh accurately, place in a 20 mL volumetric flask, add appropriate amount of solvent to dissolve and dilute to scale, shake well. (4 mg / mL).

[0185] Self-control solution: Accurately measure 1 mL of the test solution, place it in a 100 mL volumetric flask, dilute to the mark with solvent, and shake well. (1 vol%)

[0186] Impurity stock solution: take nicotinic acid, 3-cyanopyridine, ethyl nicotinamide, nicotinic acid nitrogen oxide, N Precisely weigh about 4 mg each of -ethylnicotinamide N-oxide and nikethamide N-oxide, place in 20 mL volumetric flasks, add appropriate amount of solvent to dissolve and dilute to the mark, and shake well.

[0187] Mixed impurity stock solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in a 10 mL volumetric flask, dilute to the mark with solvent, and shake well.

[0188] Positioning solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in 10 mL volumetric flasks, dilute to the mark with solvent, shake well, and use them as the respective impurity positioning solutions.

[0189] System suitability solution: Take about 80 mg of nikethamide, weigh accurately, place in a 20 mL volumetric flask, accurately add 4 mL of mixed impurity stock solution, dilute to the mark with solvent, and shake well.

[0190] III. Operation:

[0191] Accurately measure 10 μL of the above solvents, system suitability solution, each impurity location solution, test solution and control solution, inject them into the liquid chromatograph, and record the chromatogram.

[0192] IV. Test results:

[0193] As shown in Table 12 below:

[0194] Table 12

[0195]

[0196] As shown in Table 12 above and below Figure 2As shown, although the blank solvent does not interfere with the detection of the main component and each impurity, the retention time of 3-cyanopyridine and ethyl nicotinamide impurities is the same, and the separation degree does not meet the requirements; and the separation degree of nicotinic acid nitrogen oxides and ethyl nicotinamide is 0.696, which does not meet the detection requirements; the theoretical plate number of nicotinic acid nitrogen oxide peak is 249, and the peak shape is poor; the tailing factor of the nicotinic acid peak is 2.022, and its theoretical plate number is 1640, and the peak shape is poor. Therefore, the Chinese Pharmacopoeia method used in Comparative Example 1 cannot detect and separate N -Ethylnicotinamide N-oxide, nikethamide N-oxide, 3-cyanopyridine, ethylnicotinamide, nicotinic acid N-oxide, nicotinic acid and nikethamide.

[0197] Comparative Example 2

[0198] This comparative example provides a method for detecting impurities in a nikethamide raw material, and the method for detecting impurities in the nikethamide raw material comprises the following steps:

[0199] I. Chromatographic conditions:

[0200] Chromatographic column: Aglient C18 4.6×250 mm, 5 μm 125#;

[0201] Mobile phase: methanol-0.05% phosphoric acid solution (volume ratio 30:70);

[0202] Detection wavelength: 263nm;

[0203] Injection volume: 10 μL;

[0204] Flow rate: 1 mL / min;

[0205] Column temperature: 25℃.

[0206] Ⅱ. Solution preparation:

[0207] Solvent: Water.

[0208] Preparation of test solution: Take 80 mg of nikethamide, weigh accurately, place in a 20 ml volumetric flask, add appropriate amount of solvent to dissolve and dilute to scale, shake well. (4 mg / mL).

[0209] Self-control solution: Accurately measure 1 ml of the test solution, place it in a 100 ml volumetric flask, dilute to the mark with solvent, and shake well. (1 vol%)

[0210] Impurity stock solution: take nicotinic acid, 3-cyanopyridine, ethyl nicotinamide, nicotinic acid nitrogen oxide, N Precisely weigh about 4 mg each of -ethylnicotinamide N-oxide and nikethamide N-oxide, place in 20 mL volumetric flasks, add appropriate amount of solvent to dissolve and dilute to the mark, and shake well.

[0211] Mixed impurity stock solution: Accurately measure 1 ml of each of the above impurity stock solutions, place them in the same 10 mL volumetric flask, dilute to the scale with solvent, and shake well.

[0212] Positioning solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in 10 mL volumetric flasks, dilute to the mark with solvent, shake well, and use them as the respective impurity positioning solutions.

[0213] System suitability solution: Take about 80 mg of nikethamide, weigh accurately, place in a 20 mL volumetric flask, accurately add 4 mL of mixed impurity stock solution, dilute to the scale with solvent, and shake well.

[0214] III. Operation:

[0215] Accurately measure 10 μL of each of the above solvents, system suitability solution, mixed impurity stock solution, each impurity location solution, test solution and control solution and inject them into the liquid chromatograph to record the chromatogram.

[0216] IV. Test results:

[0217] As shown in Table 13 below:

[0218] Table 13

[0219]

[0220] As shown in Table 13 above and below Figure 3 As shown, the retention time of nicotinic acid and nicotinic acid nitrogen oxide peaks is the same, and the separation degree does not meet the requirements; N -Ethyl nicotinamide nitrogen oxides and ethyl nicotinamide peaks have the same retention time, and the separation does not meet the requirements; the separation of nikethamide and 3-cyanopyridine peaks does not reach the baseline separation requirement. Therefore, the detection method used in Comparative Example 2 is not suitable for the control of nitrogen oxides in nikethamide, and it is impossible to detect and separate N -Ethylnicotinamide N-oxide, nikethamide N-oxide, 3-cyanopyridine, ethylnicotinamide, nicotinic acid N-oxide, nicotinic acid and nikethamide.

[0221] Comparative Example 3

[0222] This comparative example provides a method for detecting impurities in a nikethamide raw material, and the method for detecting impurities in the nikethamide raw material comprises the following steps:

[0223] I. Chromatographic conditions:

[0224] Chromatographic column: phenomenex Kinetex EVO C18 250×4.6 mm, 5 μm 124#;

[0225] Mobile phase A: 0.05% phosphoric acid in water;

[0226] Mobile phase B: methanol;

[0227] Column temperature: 30°C;

[0228] Detection wavelength: 263 nm;

[0229] Injection volume: 10 μL;

[0230] Flow rate: 1.0 mL / min;

[0231] Gradient Program:

[0232]

[0233] Ⅱ. Solution preparation:

[0234] Solvent: Mobile phase A

[0235] Impurity stock solution: take nicotinic acid, 3-cyanopyridine, ethyl nicotinamide, nicotinic acid nitrogen oxide, N Precisely weigh about 4 mg each of -ethylnicotinamide N-oxide and nikethamide N-oxide, place in 20 mL volumetric flasks, add appropriate amount of solvent to dissolve and dilute to the mark, and shake well.

[0236] Mixed impurity stock solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in the same 10 mL volumetric flask, add solvent to dilute to the scale, and shake well.

[0237] Location solution: Accurately measure 1 mL of each of the above impurity stock solutions, place them in 10 mL volumetric flasks, add solvent to dilute to the mark, shake well, and use them as the respective impurity location solutions.

[0238] System suitability solution: Take about 80 mg of nikethamide, weigh accurately, place in a 20 mL volumetric flask, accurately add 4 mL of mixed impurity stock solution, dissolve and dilute to the scale with an appropriate amount of solvent, and shake well.

[0239] III. Operation:

[0240] Accurately measure 10 μL of the above solvents, system suitability solution, and each impurity location solution, inject them into the liquid chromatograph, and record the chromatogram.

[0241] IV. Test results:

[0242] As shown in Table 14 below:

[0243] Table 14

[0244]

[0245] As shown in Table 14 above and below Figure 4 As shown, in this comparative example, nicotinic acid nitrogen oxides, N-Ethyl nicotinamide nitrogen oxides can be effectively detected, and the minimum separation between the adjacent peaks is 6.769 and 10.887, but the separation between nikethamide and nikethamide nitrogen oxides is 0.52. Since the difference between it and Example 1 is only that the chromatographic column is different, this shows that although the chromatographic column used in Comparative Example 3 can remain stable in the range of pH 1 to 12 and is suitable for the separation of alkaline compounds, it is not suitable for the control of nitrogen oxides in nikethamide, and it is impossible to detect and separate nikethamide and nikethamide nitrogen oxides.

[0246] Comparative Example 4

[0247] This comparative example provides a method for detecting impurities in a nikethamide raw material, and the method for detecting impurities in the nikethamide raw material comprises the following steps:

[0248] I. Chromatographic conditions:

[0249] Column: Waters Sun Fire C18 250 × 4.6 mm, 5 μm;

[0250] Mobile phase A: 0.05% phosphoric acid solution;

[0251] Mobile phase B: methanol;

[0252] Column temperature: 30°C;

[0253] Detection wavelength: 263 nm;

[0254] Injection volume: 10 μL;

[0255] Flow rate: 1.0 mL / min;

[0256] Gradient Program:

[0257]

[0258] Ⅱ. Solution preparation:

[0259] Completely consistent with Example 1.

[0260] III. Operation:

[0261] Accurately measure 10 μL of the above solvents, system suitability solution, each impurity location solution, test solution and reference solution and inject them into the liquid chromatograph to record the chromatogram.

[0262] IV. Test results:

[0263] As shown in Table 15 below:

[0264] Table 15

[0265]

[0266] As shown in Table 15 above and below Figure 5 As shown, the blank solvent does not interfere with the detection, the retention time of the main peak is close to that of the 3-cyanopyridine impurity, and the separation does not meet the requirements. This method is not suitable for the detection of nikethamide-related substances and related nitrogen oxide impurities.

[0267] Comparative Example 5

[0268] This comparative example provides a method for detecting impurities in a nikethamide raw material, and the method for detecting impurities in the nikethamide raw material comprises the following steps:

[0269] I. Chromatographic conditions:

[0270] Chromatographic column: phenomenex luna C18 (2) 250×4.6mm, 5μm 171#;

[0271] Mobile phase A: 0.05% trifluoroacetic acid solution;

[0272] Mobile phase B: methanol;

[0273] Column temperature: 30°C;

[0274] Detection wavelength: 263 nm;

[0275] Injection volume: 10 μL;

[0276] Flow rate: 1.0 mL / min;

[0277] Gradient Program:

[0278]

[0279] Ⅱ. Solution preparation:

[0280] Completely consistent with Example 1.

[0281] III. Operation:

[0282] Accurately measure 10 μL of the above solvents, system suitability solution, each impurity location solution, test solution and reference solution and inject them into the liquid chromatograph to record the chromatogram.

[0283] IV. Test results:

[0284] As shown in Table 16 below:

[0285] Table 16

[0286]

[0287] As shown in Table 16 above and below Figure 6As shown in the figure, after replacing phosphoric acid in the mobile phase with trifluoroacetic acid of the same concentration, the blank solvent does not interfere with the detection, the retention time of nicotinic acid nitrogen oxides and ethyl nicotinamide impurities is the same, and the separation degree does not meet the requirements; the separation degrees between other known impurities and between the main peak and adjacent impurities meet the requirements. After changing the type of mobile phase acid, it is not suitable for the detection of nikethamide-related substances and related nitrogen oxide impurities.

[0288] Comparative Example 6

[0289] This comparative example provides a method for detecting impurities in a nikethamide raw material, which differs from Example 1 only in that the gradient program is as follows:

[0290]

[0291] Test results:

[0292] As shown in Table 17 below:

[0293] Table 17

[0294]

[0295] As shown in Table 17 above and below Figure 7 As shown, the blank solvent does not interfere with the detection, the retention time of nikethamide nitrogen oxide is the same as that of nikethamide, and the separation degree does not meet the requirements; the separation degrees between other known impurities meet the requirements. After changing the elution gradient, it is not suitable for the detection of nikethamide related substances and related nitrogen oxide impurities.

[0296] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein with equivalents. However, these modifications or replacements do not cause the essence of the corresponding technical solutions to deviate from the scope of the technical solutions of the embodiments of the present invention.

Claims

1. A method for detecting impurities in nikethamide raw materials, characterized in that, The detection method is to detect by high performance liquid chromatography, and the chromatographic conditions are: A phenomenex luna C18(2) column was used for gradient elution with aqueous phosphoric acid as mobile phase A and methanol as mobile phase B; Wherein, the impurities in the nikethamide raw material include nicotinic acid, nicotinic acid nitrogen oxide, ethyl nicotinamide, N -Ethylnicotinamide N-oxide, 3-cyanopyridine or nikethamide N-oxide, any one or a combination of at least two; The conditions of the gradient elution include: 0-5 min, the volume ratio of mobile phase A was 95%, and the volume ratio of mobile phase B was 5%; 5-20 min, mobile phase A volume ratio is 95-90%, mobile phase B volume ratio is 5-10%; 20-30 min, mobile phase A volume ratio is 90-35%, mobile phase B volume ratio is 10-65%; 30-40 min, mobile phase A volume ratio is 35%, mobile phase B volume ratio is 65%.

2. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The specifications of the chromatographic column are 250×4.6 mm, 5 μm.

3. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The mobile phase A is a 0.04-0.06 vol% phosphoric acid aqueous solution.

4. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The conditions of the gradient elution also include: 40-40.01 min, the volume ratio of mobile phase A was 35-95%, and the volume ratio of mobile phase B was 65-5%; 40.01-50 min, the volume ratio of mobile phase A was 95%, and the volume ratio of mobile phase B was 5%.

5. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The detection method comprises the following steps: Dissolving the nikethamide raw material in the mobile phase A to obtain a test solution; and then injecting the test solution into a high performance liquid chromatograph for detection and separation; And / or, the concentration of the test solution is 3.0~5.0 mg / mL.

6. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The flow rate of the detection is 0.8~1.2 mL / min.

7. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The column temperature of the detection is 25~35°C.

8. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The detection wavelength is 260-265 nm.

9. The method for detecting impurities in nikethamide raw material according to claim 1, characterized in that: The injection volume for the test was 8-12 μL.

Citation Information

Patent Citations

  • Heteroaryl substituted nicotinamide compounds

    CN106061967A

  • HPLC related substance analysis method of medical substances

    CN113267584A

  • Triazolopyridazine derivative as well as preparation method, pharmaceutical composition and application thereof

    CN114302886A

  • Preparation of nikethamide nitrogen oxide impurity

    CN117263857A

  • Substituted 2,3-diphenyl pyridines

    US20050182103A1